Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Current Pharmaceutical Design|January 14, 2012
Economic impact of early detection and early intervention of psychosisLucia R Valmaggia, Philip K McGuire, Paolo Fusar-Poli, et al.
JAMA Network Open|January 16, 2019
Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode PsychosisFaith Borgan, Owen O'Daly, Karen Hoang, et al.
Journal of Psychopharmacology (Oxford, England)|August 22, 2018
The effects of haloperidol on microglial morphology and translocator protein levels: An in vivo study in rats using an automated cell evaluation pipelinePeter S Bloomfield, David Bonsall, Lisa Wells, et al.
Current Pharmaceutical Design|October 2, 2014
The role of white matter abnormalities in treatment-resistant depression: a systematic reviewGianluca Serafini, Maurizio Pompili, Stefan Borgwardt, et al.
Psychological Medicine|June 17, 2026
Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophreniaRicardo Twumasi, Frederikke Hørdam Gronemann, Carsten Hjorthøj, et al.
IEEE Transactions on Bio-Medical Engineering|October 12, 2018
A Unified Framework for Plasma Data Modeling in Dynamic Positron Emission Tomography StudiesMatteo Tonietto, Gaia Rizzo, Mattia Veronese, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 26, 2019
Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletionMaria Rogdaki, Pamela Hathway, Maria Gudbrandsen, et al.
Journal of Affective Disorders|August 5, 2020
The magnitude and heterogeneity of antidepressant response in depression: A meta-analysis of over 45,000 patientsXin Guo, Robert A McCutcheon, Toby Pillinger, et al.
Pageof 14